EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mycosis Fungoides and Sézary Syndrome: Microenvironment and Cancer Progression

Gabor Dobos iD, Ingrid Lazaridou, Adèle de Masson iD

Cancers · 25.01.2023 · 15 (3) · 746

DOI: 10.3390/cancers15030746 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 25.01.2023. Verfasst von Gabor Dobos und 2 weiteren Autor:innen. Beteiligte Einrichtung: Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt, 10117 Berlin, Germany. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycosis fungoides and Sézary syndrome are epidermotropic cutaneous lymphomas, and both of them are rare diseases. Mycosis fungoides is the most frequent primary cutaneous lymphoma. In about 25% of patients with mycosis fungoides, the disease may progress to higher stages. The pathogenesis and risk factors of progression in mycosis fungoides and Sézary syndrome are not yet fully understood. Previous works have investigated inter- and intrapatient tumor cell heterogeneity. Here, we overview the role of the tumor microenvironment of mycosis fungoides and Sézary syndrome by describing its key components and functions. Emphasis is put on the role of the microenvironment in promoting tumor growth or antitumor immune response, as well as possible therapeutic targets. We focus on recent advances in the field and point out treatment-related alterations of the microenvironment. Deciphering the tumor microenvironment may help to develop strategies that lead to long-term disease control and cure.

Schlagwörter

Stichwörter der Autor:innen

Sézary syndromecutaneous T-cell lymphomasmicroenvironmentmycosis fungoides

Autor:innen und Institutionen

  • Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt, 10117 Berlin, Germany.
  • Department of Dermatology, Universität zu Berlin, 10117 Berlin, Germany.
  • Dermatology, Brown University, Providence, RI 02912, USA.
  • Dermatology Department, Saint-Louis Hospital, AP-HP, 75010 Paris, France.
  • Department of Medicine, Université Paris Cité, 75010 Paris, France.

ORCID-Profile: Gabor Dobos, Adèle de Masson

Zitieren

APA

Dobos, G., Lazaridou, I., & de Masson, A. (2023). Mycosis Fungoides and Sézary Syndrome: Microenvironment and Cancer Progression. Cancers, 15(3), 746. https://doi.org/10.3390/cancers15030746

Vancouver

Dobos G, Lazaridou I, de Masson A. Mycosis Fungoides and Sézary Syndrome: Microenvironment and Cancer Progression. Cancers. 2023;15(3):746. doi:10.3390/cancers15030746

BibTeX
@article{Dobos2023,
  author = {Dobos, Gabor and Lazaridou, Ingrid and de Masson, Adèle},
  title = {Mycosis Fungoides and Sézary Syndrome: Microenvironment and Cancer Progression},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {746},
  doi = {10.3390/cancers15030746}
}
Kostenlos starten →